- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Late-life Depression in Argentina
Total 65 results
-
AstraZenecaCompletedNon-psychotic Unipolar Major DepressionArgentina
-
SanofiCompletedMajor Depressive DisorderUnited States, France, Sweden, Mexico, Argentina, Finland
-
SanofiCompletedDepressive Disorder | Major DepressionFrance, Poland, Romania, Russian Federation, Bulgaria, Serbia, Slovakia, Czech Republic, Mexico, Argentina, Croatia, Finland, South Africa
-
Universidad Nacional de RosarioCompletedDepression | AnxietyArgentina
-
SanofiCompletedDepressive DisorderCanada, Russian Federation, Bulgaria, Mexico, Argentina, Chile, Croatia
-
SanofiCompletedMajor Depressive DisordersRussian Federation, Spain, Singapore, Taiwan, Tunisia, Argentina, Chile, Hong Kong, Morocco, South Africa, Greece
-
Janssen Research & Development, LLCCompletedTreatment-resistant DepressionUnited States, Australia, France, United Kingdom, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Poland, Bulgaria, Malaysia, South Africa, Turkey, Finland, Korea, Republic of, Brazil, Austria, Sweden, Lithuania
-
Sanatorio Anchorena San MartinCagide Sabrina; Di giorgio Victoria; Villalba Dario; Accoce MatiasCompletedPost-intensive Care SyndromeArgentina
-
Eli Lilly and CompanyCompletedTreatment Resistant DepressionUnited States, Argentina, Russian Federation, South Africa, India, Turkey, Puerto Rico, Mexico
-
AstraZenecaCompletedAcute Bipolar DepressionBrazil, Mexico, Peru, Turkey, Argentina, Chile, Venezuela, Colombia, Guatemala
-
AstraZenecaCompleted
-
Janssen-Cilag Ltd.Active, not recruitingDepressive Disorder, MajorTaiwan, Turkey, Malaysia, Germany, Czechia, Korea, Republic of, Poland, Hungary, Argentina, Belgium, Bulgaria, Finland, Greece, South Africa
-
Intra-Cellular Therapies, Inc.Active, not recruitingMajor Depressive DisorderUnited States, Bulgaria, Germany, Poland, Finland, Sweden, Argentina
-
Argentinian Intensive Care SocietyCompletedHealthy Volunteers | Respiratory Rate | DiaphragmArgentina
-
AstraZenecaCompletedMajor Depressive DisorderRussian Federation, United States, Estonia, Ukraine, Finland, Argentina
-
Eli Lilly and CompanyCompletedDepressive Disorder, MajorUnited States, Finland, Poland, Russian Federation, Argentina
-
Eli Lilly and CompanyCompletedMajor Depressive DisorderMexico, United States, Argentina, Canada
-
Universidad Nacional de RosarioUnknown
-
GlaxoSmithKlineCompletedDepressive Disorder, MajorBelgium, Peru, Argentina, Chile, Costa Rica, Slovakia, Italy, Germany, Poland, Spain, Sweden
-
Janssen Research & Development, LLCTerminatedDepressive Disorder, MajorUnited States, Korea, Republic of, Malaysia, Poland, Finland, Chile, Argentina, Slovakia, Ukraine, Denmark
-
Eli Lilly and CompanyCompletedMajor Depressive DisorderUnited States, Germany, Italy, Turkey, Russian Federation, Korea, Republic of, Greece, France, Croatia, Romania, Spain, Argentina, Puerto Rico, Belgium, Mexico, Slovakia
-
Hospital Nacional Profesor Alejandro PosadasInstituto Ecuatoriano de Enfermedades Digestivas; Hospital Nacional Cayetano...RecruitingQuality of Life | Inflammatory Bowel Diseases | Knowledge, Attitudes, Practice | Treatment Adherence and ComplianceArgentina
-
H. Lundbeck A/SCompletedMajor Depressive DisorderSpain, Czechia, Slovakia, Estonia, Sweden, Argentina, Belgium, Bulgaria, Latvia, Mexico, Russian Federation, Ukraine
-
ShireCompletedMajor Depressive DisorderUnited States, Chile, Australia, Argentina, United Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedDepressive Disorder | Depression | Depressive Disorder, MajorColombia, Mexico, United States, Peru, Chile, Argentina
-
Boehringer IngelheimCompletedA Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With DepressionDepressive Disorder, MajorSpain, United States, Canada, Germany, Japan, Argentina, Hungary, France, Australia, Bulgaria, Czechia, Poland, Russian Federation, Slovakia
-
AstraZenecaTargacept Inc.CompletedMajor Depressive DisorderCroatia, Brazil, Bulgaria, France, Poland, Russian Federation, South Africa, Hungary, Romania, Ukraine, Argentina, Chile, Slovakia, Colombia, Germany, Serbia, Spain
-
Universidad Nacional de RosarioCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing RemittingArgentina
-
Novartis PharmaceuticalsTerminatedMajor Depressive Disorder With Suicidal Ideation With IntentTaiwan, Spain, Germany, Netherlands, Turkey, Mexico, United States, Malaysia, Poland, Canada, Japan, Russian Federation, Argentina, Brazil
-
Janssen-Cilag International NVCompletedDepressive Disorder, MajorIsrael, Hungary, Korea, Republic of, Taiwan, Portugal, Turkey, Germany, Malaysia, Denmark, Bulgaria, Czechia, Belgium, Poland, Brazil, Netherlands, Argentina, Finland, Greece, South Africa, Austria, Kazakhstan, Norway, Sweden, United...
-
TakedaTerminatedAcute Depressive EpisodeUnited States, Argentina, Chile, Colombia, Mexico
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorUnited States, Belgium, Czechia, Ukraine, Poland, Malaysia, Serbia, Bulgaria, Argentina, Lithuania, Slovakia, Russian Federation, Canada, United Kingdom, Latvia
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisArgentina
-
Janssen Research & Development, LLCRecruitingDepressive Disorder, MajorUnited States, Korea, Republic of, Taiwan, Slovakia, Spain, Bulgaria, Portugal, Poland, Belgium, Argentina, Czechia, Hungary, South Africa, Sweden, Italy, France, Australia, China, Brazil
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorUnited States, Belgium, Canada, Poland, France, Spain, Brazil, Lithuania, Czechia, Austria, Argentina, Turkey
-
Mela Osorio Maria JoseJanssen-Cilag Ltd.Completed
-
Merck KGaA, Darmstadt, GermanyMerck Quimica Argentina S.A.I.CCompletedMultiple Sclerosis, Relapsing RemittingArgentina
-
CephalonCompletedDepressionSpain, United States, Poland, Canada, South Africa, Argentina, Australia, Bulgaria, France, Ukraine
-
Janssen Research & Development, LLCCompletedDepressive Disorder, Treatment-ResistantUnited States, France, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Bulgaria, Malaysia, South Africa, Turkey, Canada, Korea, Republic of, Brazil, Estonia, Hungary, Lithuania, Slovakia, Sweden, Czechia, A... and more
-
CephalonCompletedDepressionUnited States, Argentina, Brazil, Bulgaria, Croatia, Finland, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Ukraine
-
Bristol-Myers SquibbCompletedDepressionItaly, South Africa, United States, Australia, Argentina, Canada, Austria, France, Spain, India, Puerto Rico, United Kingdom
-
CephalonTerminatedDepressionUnited States, Argentina, Australia, Brazil, Bulgaria, Canada, Croatia, France, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Spain, Ukraine
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-remittingArgentina
-
Bristol-Myers SquibbTerminatedDepressionFrance, South Africa, Sweden, United States, Australia, Italy, Argentina, Austria, Spain, Finland, India, Puerto Rico
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisArgentina
-
Janssen Research & Development, LLCRecruitingDepressive Disorder, MajorUnited States, Korea, Republic of, Brazil, Spain, Argentina, United Kingdom, Sweden, Italy, Germany, France, Canada
-
University of BergenUniversity of Campinas, Brazil; University of Liverpool; University Medical Center... and other collaboratorsCompletedNeoplasms | Quality of Life | BereavementNorway, United Kingdom, Germany, Argentina, Brazil, Poland, Uruguay
-
AstraZenecaCompleted
-
Janssen Research & Development, LLCRecruitingAnhedonia | Depressive Disorder, MajorUnited States, Spain, Bulgaria, Italy, Poland, Belgium, Argentina, Czechia, Hungary, Sweden, Brazil, Australia, Portugal